These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30972192)

  • 1. Overexpression of CBX2 in breast cancer promotes tumor progression through the PI3K/AKT signaling pathway.
    Zheng S; Lv P; Su J; Miao K; Xu H; Li M
    Am J Transl Res; 2019; 11(3):1668-1682. PubMed ID: 30972192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression and significance of chromobox protein homolog 2 in breast cancer].
    Guo XH; Zhang JY; Jiao DC; Zhu JJ; Ma YZ; Yang Y; Xiao H; Liu ZZ
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(2):130-135. PubMed ID: 31937053
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer.
    Chen WY; Zhang XY; Liu T; Liu Y; Zhao YS; Pang D
    Oncol Lett; 2017 Mar; 13(3):1149-1156. PubMed ID: 28454227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
    Li J; Guo ZX; Chen JA; Xue C; Sun LL; Ren ZG; Li A; Cui GY; Yu ZJ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):192-197. PubMed ID: 30929335
    [No Abstract]   [Full Text] [Related]  

  • 5. The predictive significance of chromobox family members in prostate cancer in humans.
    Xu X; Lai C; Luo J; Shi J; Guo K; Hu J; Mulati Y; Xiao Y; Kong D; Liu C; Huang J; Xu K
    Cell Oncol (Dordr); 2024 Aug; 47(4):1315-1331. PubMed ID: 38427207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses.
    Zhou H; Xiong Y; Liu Z; Hou S; Zhou T
    Cancer Cell Int; 2021 Jul; 21(1):402. PubMed ID: 34321009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer.
    Iqbal MA; Siddiqui S; Ur Rehman A; Siddiqui FA; Singh P; Kumar B; Saluja D
    Mol Oncol; 2021 May; 15(5):1450-1465. PubMed ID: 33400401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer.
    Wheeler LJ; Watson ZL; Qamar L; Yamamoto TM; Post MD; Berning AA; Spillman MA; Behbakht K; Bitler BG
    Oncogenesis; 2018 Nov; 7(11):92. PubMed ID: 30478317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBX2 Deletion Suppresses Growth and Metastasis of Colorectal Cancer by Mettl3-p38/ERK MAPK Signalling Pathway.
    Sun R; Tu X; Chan S; Wang X; Ji Y; Wang Z; Yu Z; Zuo X; Zhang Q; Chen J; Han Q; Wang M; Zhao H; Zhang H; Chen W
    J Cancer; 2024; 15(8):2123-2136. PubMed ID: 38495501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma.
    Mao J; Tian Y; Wang C; Jiang K; Li R; Yao Y; Zhang R; Sun D; Liang R; Gao Z; Wang Q; Wang L
    J Cancer; 2019; 10(12):2706-2719. PubMed ID: 31258779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma.
    Piqué DG; Montagna C; Greally JM; Mar JC
    Br J Cancer; 2019 Apr; 120(7):746-753. PubMed ID: 30820027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
    Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
    Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth.
    Bilton LJ; Warren C; Humphries RM; Kalsi S; Waters E; Francis T; Dobrowinski W; Beltran-Alvarez P; Wade MA
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
    Wang Y; Liu C; Xie Z; Lu H
    Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZKSCAN3 promotes breast cancer cell proliferation, migration and invasion.
    Chi Y; Xu H; Wang F; Chen X; Shan Z; Sun Y; Fan Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2583-2589. PubMed ID: 30049438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma.
    Iwanaga R; Yamamoto TM; Gomez K; Nguyen LL; Woodruff ER; Post MD; Mikeska RG; Danis E; Danhorn T; Boorgula MP; Mitra SS; Marjon NA; Bitler BG; Brubaker LW
    Cancer Res Commun; 2024 Aug; 4(8):1919-1932. PubMed ID: 38984891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
    He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
    Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM‑1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo.
    Yin J; Li X; Zhang Z; Luo X; Wang L; Liu L
    Int J Oncol; 2018 Jul; 53(1):297-306. PubMed ID: 29749435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.